(Updated - April 24, 2026 5:08 AM EDT)

Goldman Sachs analyst Corinne Johnson upgraded Altimmune (NASDAQ: ALT) from Sell ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE